NORTH HAVEN, Conn.--(BUSINESS WIRE)--Covidien Ltd. (NYSE: COV, BSX: COV), a leading global provider of healthcare products, has introduced the PleuraSeal™ Lung Sealant System to the European market. The PleuraSeal™ Lung Sealant System, CE Mark approved, is intended for use as a surgical sealant during elective pulmonary resection as an adjunct for standard closure techniques of visceral pleural air leaks.
